Tien Liang BioTech Co., Ltd. (TPEX:4127)

Taiwan · Delayed Price · Currency is TWD

88.80

-3.50 (-3.79%)

Aug 19, 2026, 1:30 PM CST

Tien Liang BioTech Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	650.87	511.79	385.21	459.99	528.52	571.32
Revenue Growth	52.12%	32.86%	-16.26%	-12.97%	-7.49%	32.53%
Gross Profit	379.37	287.94	229.91	286.15	336.55	338.28
Operating Income	5.66	-16.14	0.59	18.87	58.29	42.95
Net Income	69.09	-10.25	11.7	17.73	59.48	46.61
Earnings Per Share	1.51	-0.22	0.26	0.39	1.30	1.02
EPS Growth	-	-	-34.04%	-70.19%	27.63%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	197.11	152.31	130.67	142.22	107.84	118.47
Total Debt	598	598	335.38	70.88	101.4	132.67
Net Cash (Debt)	-400.9	-445.69	-204.71	71.34	6.44	-14.21
Net Cash Growth	-	-	-	1007.04%	-	-
Net Cash Per Share	-8.75	-9.74	-4.47	1.56	0.14	-0.31

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	47.11	19.23	48.66	69.67	21.88	45.21
Capital Expenditures	-22.83	-23.19	-4.05	-4.96	-1.01	-0.6
Free Cash Flow	24.28	-3.96	44.61	64.71	20.87	44.61
Free Cash Flow Growth	-40.54%	-	-31.05%	210.05%	-53.22%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	58.29%	56.26%	59.69%	62.21%	63.68%	59.21%
Operating Margin	0.87%	-3.15%	0.15%	4.10%	11.03%	7.52%
Pretax Margin	10.64%	-2.30%	3.40%	4.00%	11.23%	8.54%
Profit Margin	10.62%	-2.00%	3.04%	3.85%	11.25%	8.16%
FCF Margin	3.73%	-0.77%	11.58%	14.07%	3.95%	7.81%

Dividends

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Dividend Per Share	0.500
Dividend Per Share Growth	-
Dividend Yield	3.50%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	61.19	-	162.37	37.42	11.89	14.53
Forward PE	-	10.79	10.79	10.79	10.79	10.79
P/FCF Ratio	173.96	-	42.57	10.25	33.88	15.18
PS Ratio	6.49	2.77	4.93	1.44	1.34	1.19